###begin article-title 0
Activation of Steroid and Xenobiotic Receptor (SXR, NR1I2) and Its Orthologs in Laboratory, Toxicologic, and Genome Model Species
###end article-title 0
###begin p 1
Current address: Conservation and Research for Endangered Species, Zoological Society of San Diego, Escondido, California, USA.
###end p 1
###begin p 2
Current address: Focus Diagnostics, Cypress, California, USA.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 116 122 <span type="species:ncbi:9606">humans</span>
Nuclear receptor subfamily 1, group I, member 2 (NR1I2), commonly known as steroid and xenobiotic receptor (SXR) in humans, is a key ligand-dependent transcription factor responsible for the regulation of xenobiotic, steroid, and bile acid metabolism. The ligand-binding domain is principally responsible for species-specific activation of NR1I2 in response to xenobiotic exposure.
###end p 4
###begin title 5
Objectives
###end title 5
###begin p 6
Our objective in this study was to create a common framework for screening NR1I2 orthologs from a variety of model species against environmentally relevant xenobiotics and to evaluate the results in light of using these species as predictors of xenobiotic disposition and for assessment of environmental health risk.
###end p 6
###begin title 7
Methods
###end title 7
###begin p 8
Sixteen chimeric fusion plasmid vectors expressing the Gal4 DNA-binding domain and species-specific NR1I2 ligand-binding domain were screened for activation against a spectrum of 27 xenobiotic compounds using a standardized cotransfection receptor activation assay.
###end p 8
###begin title 9
Results
###end title 9
###begin p 10
NR1I2 orthologs were activated by various ligands in a dose-dependent manner. Closely related species show broadly similar patterns of activation; however, considerable variation to individual compounds exists, even among species varying in only a few amino acid residues.
###end p 10
###begin title 11
Conclusions
###end title 11
###begin p 12
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Interspecies variation in NR1I2 activation by various ligands can be screened through the use of in vitro NR1I2 activation assays and should be taken into account when choosing appropriate animal models for assessing environmental health risk.
###end p 12
###begin p 13
###xml 217 234 217 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp0116-000880">Hans Selye (1971)</xref>
###xml 361 390 361 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp0116-000880">Einarsson and Gustafsson 1973</xref>
###xml 632 690 632 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0116-000880">National Center for Biotechnology Information (NCBI) 2007b</xref>
###xml 901 921 901 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0116-000880">Blumberg et al. 1998</xref>
###xml 973 992 973 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp0116-000880">Kliewer et al. 1998</xref>
###xml 994 1013 994 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp0116-000880">Lehmann et al. 1998</xref>
###xml 1051 1068 1051 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000880">Moore et al. 2002</xref>
###xml 1116 1132 1116 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0116-000880">Gr&#252;n et al. 2002</xref>
###xml 1415 1431 1415 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-ehp0116-000880">Xie et al. 2000b</xref>
###xml 1433 1437 1433 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0116-000880">2004</xref>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 1016 1023 <span type="species:ncbi:9031">chicken</span>
The ability of a xenobiotic substance to induce protection against subsequent exposure and also to induce protection against exposure to other potentially toxic compounds was first described more than 30 years ago by Hans Selye (1971). It was quickly realized that such "catatoxic" compounds led to an increase in hepatic cytochrome P450 (CYP) enzyme activity (Einarsson and Gustafsson 1973) and that the substrates of the activated enzymes were relatively nonspecific. In 1998, activation of human CYP3A4 was shown to be primarily mediated by nuclear receptor subfamily 1, group I, member 2 [NR1I2; GenBank accession no. AY091855; National Center for Biotechnology Information (NCBI) 2007b]. For purposes of clarification, we use the trivial names of NR1I2 orthologs associated with specific taxonomic groups. This receptor is commonly known as the steroid and xenobiotic receptor (SXR) in primates (Blumberg et al. 1998), pregnane X receptor (PXR) in nonprimate mammals (Kliewer et al. 1998; Lehmann et al. 1998), chicken X receptor (CXR) in birds (Moore et al. 2002), and benzoate X receptor (BXR) in amphibians (Grun et al. 2002). It is now well established that the most prevalent CYP enzymes in the liver, members of the CYP3A and 2B subfamilies, along with a host of conjugating enzymes and ATP binding cassette (ABC) family membrane transport proteins, are under direct transcriptional regulation by NR1I2 (Xie et al. 2000b, 2004).
###end p 13
###begin p 14
###xml 137 156 137 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-ehp0116-000880">Kliewer et al. 2002</xref>
###xml 774 798 774 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp0116-000880">Dussault and Forman 2002</xref>
###xml 800 827 800 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-ehp0116-000880">Kretschmer and Baldwin 2005</xref>
###xml 1078 1098 1078 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0116-000880">Blumberg et al. 1998</xref>
###xml 1100 1117 1100 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp0116-000880">Jones et al. 2000</xref>
###xml 1119 1135 1119 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0116-000880">Tabb et al. 2004</xref>
Through the action of its target genes, NR1I2 is a key regulator of bile salt, steroid hormone, and xenobiotic metabolism and excretion (Kliewer et al. 2002). NR1I2 is a member of the nuclear hormone receptor superfamily, which also includes sex steroid receptors, thyroid receptor, and other orphan receptors such as constitutive androstane receptor (CAR, NR1I3). The term "orphan receptor" has been given to a number of transcription factors that are related to nuclear receptors but for which a definitive endogenous ligand was not initially identified. Ligand-dependent activation of NR1I2 is mediated by steroid hormones, dietary compounds (e.g., phytoestrogens), vitamins E and K, medicinal herbs, xenobiotics, and approximately 50% of prescription drugs (reviewed by Dussault and Forman 2002; Kretschmer and Baldwin 2005). These ligands are extremely varied in chemical structure and application, and some have been shown to activate or antagonize NR1I2 orthologs in a species-specific manner (e.g., rifampicin, coumestrol, highly chlorinated polychlorinated biphenyls) (Blumberg et al. 1998; Jones et al. 2000; Tabb et al. 2004).
###end p 14
###begin p 15
###xml 127 143 127 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000880">Xie et al. 2000a</xref>
###xml 801 818 801 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000880">Moore et al. 2002</xref>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 225 230 <span type="species:ncbi:9606">human</span>
###xml 764 771 <span type="species:ncbi:9031">chicken</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
###xml 924 930 <span type="species:ncbi:9606">humans</span>
###xml 1223 1229 <span type="species:ncbi:9606">humans</span>
Development of the so-called humanized mouse was an important step in understanding the pharmacology of xenobiotic metabolism (Xie et al. 2000a). This animal is deficient in the rodent NR1I2 ortholog, PXR, and transgenic for human SXR expression in the liver. This model demonstrates convincingly that NR1I2 is the key regulator of CYP3A expression and that selective activation of target genes in response to species-specific activators depends on the ligand-binding domain (LBD) of this receptor, rather than on the DNA-binding domain (DBD) or target DNA-binding elements. The primary sequence of the LBD for NR1I2 varies greatly across species. The sequence similarity can be as low as 75% between mammalian NR1I2 orthologs and as low as 49% when comparing the chicken ortholog, CXR, to human SXR (Moore et al. 2002). A fundamental assumption made when using the results of model animal experiments to predict effects on humans or wildlife is that uptake and metabolism of the compound as well as the biochemistry and endocrinology of the organism is similar between the model species and species of concern. In some cases, the response of a model species to chemical exposure is reasonably predictive of the effects on humans. In other cases, the connection is more uncertain, and the ability to predict risk is not reliable. Understanding how the xenobiotic response differs among species is essential to developing high-quality models and characterizations of risk from chemical exposure.
###end p 15
###begin p 16
###xml 333 341 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 774 782 774 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 831 838 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 908 915 908 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-ehp0116-000880">Table 1</xref>
###xml 378 383 <span type="species:ncbi:4932">yeast</span>
###xml 1396 1402 <span type="species:ncbi:9606">humans</span>
The goal of this study was to screen a wide variety of xenobiotic compounds for interaction with NR1I2 orthologs within a common system, thus providing the framework for understanding the metabolism of xenobiotics in different model species. To compare responses correlating to interspecies variation in the LBD of NR1I2, we used an in vitro luciferase reporter assay driven by yeast Gal4 DBD-NR1I2 LBD fusion plasmids. Advantages of this system are that it eliminates the need to clone each species' bona fide response and is insensitive to induction by endogenous receptors. One disadvantage of this system is that it is insensitive to interspecies variation in activation function-1 (AF-1) region coregulator recruitment; however, the availability of coregulators in any in vitro system is not necessarily representative of the in vivo environment. A structurally diverse array of xenobiotics was chosen (Table 1) to represent a broad spectrum of chemical classes and applications that published data indicate are of considerable environmental and/or health concern. NR1I2 orthologs tested included commonly used laboratory, toxicologic, and/or genome model species. The results of these experiments have important implications for determining the appropriate use of animal models and for assessing whether we can reasonably rely on those models to predict results in other species, including humans.
###end p 16
###begin title 17
Materials and Methods
###end title 17
###begin title 18
Cloning of NR1I2 orthologs
###end title 18
###begin p 19
###xml 204 218 204 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus laevis</italic>
###xml 350 364 343 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca fuscata</italic>
###xml 388 407 381 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca fascicularis</italic>
###xml 420 438 413 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Callithrix jacchus</italic>
###xml 448 465 441 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Coturnix japonica</italic>
###xml 484 503 477 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pimephales promelas</italic>
###xml 512 529 505 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Takifugu rubripes</italic>
###xml 544 559 537 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oryzias latipes</italic>
###xml 1222 1225 1215 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1232 1235 1225 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 1270 1290 1263 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0116-000880">Blumberg et al. 1998</xref>
###xml 1298 1301 1291 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Exo</italic>
###xml 1344 1361 1337 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp0116-000880">Li and Evans 1997</xref>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 115 118 <span type="species:ncbi:9615">dog</span>
###xml 131 137 <span type="species:ncbi:9986">rabbit</span>
###xml 150 153 <span type="species:ncbi:10116">rat</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
###xml 184 191 <span type="species:ncbi:9031">chicken</span>
###xml 204 218 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 267 276 <span type="species:ncbi:7955">zebrafish</span>
###xml 332 348 <span type="species:ncbi:9542">Japanese macaque</span>
###xml 350 364 <span type="species:ncbi:9542">Macaca fuscata</span>
###xml 367 386 <span type="species:ncbi:9541">crab-eating macaque</span>
###xml 388 407 <span type="species:ncbi:9541">Macaca fascicularis</span>
###xml 420 438 <span type="species:ncbi:9483">Callithrix jacchus</span>
###xml 448 465 <span type="species:ncbi:93934">Coturnix japonica</span>
###xml 484 503 <span type="species:ncbi:90988">Pimephales promelas</span>
###xml 512 529 <span type="species:ncbi:31033">Takifugu rubripes</span>
###xml 536 542 <span type="species:ncbi:8090">medaka</span>
###xml 544 559 <span type="species:ncbi:8090">Oryzias latipes</span>
###xml 1090 1095 <span type="species:ncbi:9606">human</span>
LBD coding sequence has previously been reported in GenBank for NR1I2 orthologs in human (accession no. AY091855), dog (AF454670), rabbit (AF182217), rat (AF151377), mouse (NM010936), chicken (AF276753), Xenopus laevis BXRalpha (BC041187) and BXRbeta (AF305201), and zebrafish (AF502918). Novel NR1I2 LBD sequences were cloned from Japanese macaque (Macaca fuscata), crab-eating macaque (Macaca fascicularis), marmoset (Callithrix jacchus), quail (Coturnix japonica), fathead minnow (Pimephales promelas), fugu (Takifugu rubripes), and medaka (Oryzias latipes). For novel sequences, optimized degenerate primers (forward 5'-AGAACTAGTG-GATCCGYGARGGNTGYAARGGNTTYT T and reverse 5'-GGTATCGATAAGCTTG-CYTGCATNARNACRTAYTCYTC) were used for polymerase chain reaction (PCR) amplification of a region extending from the first zinc finger of the DBD (C E G C K G F F) into the LBD (E E Y V L M Q A) for each species. We used nested primers derived from the amplified region and 3'-RACE (rapid amplification of cDNA ends) to obtain full LBD sequences beginning with the coding region corresponding to human SXR Met-107 from liver cDNA libraries from each species. Gal4-NR1I2 fusion constructs were created by subcloning the LBD into EcoRI and BamHI sites of the vector pCMX-Gal4N (Blumberg et al. 1998) using ExoIII-mediated ligation-independent cloning (Li and Evans 1997). The PCR products were directly sequenced, and we selected GAL4-NR1I2 LBD clones that matched each consensus sequence.
###end p 19
###begin title 20
Cell culture and luciferase reporter assays
###end title 20
###begin p 21
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 396 412 393 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0116-000880">Gr&#252;n et al. 2002</xref>
###xml 414 430 411 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0116-000880">Tabb et al. 2004</xref>
###xml 1058 1074 1048 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0116-000880">Gr&#252;n et al. 2002</xref>
###xml 113 119 <span type="species:ncbi:9913">bovine</span>
COS7 cells were maintained in phenol-red-free Dulbecco's minimal Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Twenty-four hours before transfection, we seeded 96-well plates with 5 x 105 cells per plate. Chimeric receptor plasmids were cotransfected along with the tk(MH100)x4luc and pCMX-beta-galactosidase reporter plasmids using calcium-phosphate-mediated transfection (Grun et al. 2002; Tabb et al. 2004). All ligands were initially dissolved in dimethylsulfoxide (DMSO) and subsequently diluted in DMEM supplemented with 10% charcoal-resin stripped FBS with a final concentration of 0.5% DMSO. The final DMSO concentration was minimized according to the solubility limits of the test compounds and adjusted so that all treatments were carried out under the same conditions. No overt toxicity, as indicated by beta-galactosidase activity, was observed relative to untreated controls. After 24 hr of ligand exposure, we assayed 50-muL aliquots of cell lysate for luciferase and beta-galactosidase activity, as previously described (Grun et al. 2002). Luciferase activity is reported as fold activation relative to the vehicle control (0.5% DMSO) and normalized for beta-galactosidase activity. Each combination of receptor and ligand was run in triplicate at three doses and repeated whenever the coefficient of variance exceeded 0.15. Positive control ligands were assigned based on previously published data or empirically determined upon cloning of the novel orthologs. We also ran a negative control consisting of vector lacking an NR1I2 LBD for each ligand to ensure luciferase activity was not promoted via LBD-independent pathways.
###end p 21
###begin title 22
Sequence alignment and phylogenetic analysis
###end title 22
###begin p 23
###xml 69 79 69 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0116-000880">NCBI 2007a</xref>
###xml 107 117 107 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-ehp0116-000880">NCBI 2007b</xref>
###xml 138 158 138 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp0116-000880">Thompson et al. 1997</xref>
###xml 321 337 321 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp0116-000880">Felsenstein 1989</xref>
Novel sequences were checked for similarity using blastn and blastp (NCBI 2007a) and submitted to GenBank (NCBI 2007b). We used ClustalX (Thompson et al. 1997) to align deduced amino acid LBD sequences and create an identity matrix. A neighbor-joining phylogenetic tree was constructed using the PHYLIP computer program (Felsenstein 1989) using NR1I3 as a closely related outgroup.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
NR1I2 ortholog sequences
###end title 25
###begin p 26
###xml 44 52 44 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0116-000880">Figure 1</xref>
###xml 293 313 293 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-ehp0116-000880">Chrencik et al. 2005</xref>
###xml 315 334 315 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp0116-000880">Watkins et al. 2001</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-ehp0116-000880">2003</xref>
###xml 870 877 870 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 1097 1114 1097 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000880">Moore et al. 2002</xref>
###xml 152 157 <span type="species:ncbi:9606">Human</span>
###xml 726 733 <span type="species:ncbi:9986">rabbits</span>
Comparison of NR1I2 ortholog LBD sequences (Figure 1) revealed a relatively high degree of similarity among mammalian orthologs compared to nonmammals. Human SXR amino acid residues that line the LBD and interact with various ligands (shaded) have been characterized by X-ray crystallography (Chrencik et al. 2005; Watkins et al. 2001, 2003). The corresponding residues appear to be highly conserved within mammals or are typically represented by functionally similar amino acid substitutions such as nonpolar valine, leucine, and methionine, or polar serine and threonine. Notable exceptions include the substitution of serine for leucine at position 105 in rodents and leucine or isoleucine for glutamine at position 184 in rabbits and rodents. When comparing nonmammalian NR1I2 orthologs, the least conserved region is the helix 1-3 insert, almost entirely absent in Xenopus BXRs, and highly variable among avian CXRs and fish orthologs. This region is thought to facilitate expansion of the ligand-binding pocket and distinguishes NR1I2 from functionally divergent members of the NRI1 family (Moore et al. 2002).
###end p 26
###begin p 27
###xml 76 84 76 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2-ehp0116-000880">Figure 2</xref>
###xml 460 481 460 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-ehp0116-000880">Handschin et al. 2004</xref>
###xml 483 504 483 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-ehp0116-000880">Krasowski et al. 2005</xref>
Sequence similarity and associations observed in the neighbor-joining tree (Figure 2) are generally consistent with expected evolutionary relationships among the represented vertebrate classes and orders. These results also indicate that the nonmammalian orthologs are approximately equidistant from mammalian NR1I2 and NR1I3, consistent with the hypothesis that mammalian NR1I2 and NR1I3 resulted from a gene duplication of a nonmammalian ancestral ortholog (Handschin et al. 2004; Krasowski et al. 2005).
###end p 27
###begin title 28
Activation of NR1I2 othologs
###end title 28
###begin p 29
###xml 300 307 298 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-ehp0116-000880">Table 2</xref>
###xml 589 596 586 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp0116-000880">Table 3</xref>
###xml 1083 1090 1079 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0116-000880">Table 4</xref>
###xml 1229 1234 1225 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-tert</italic>
###xml 223 228 <span type="species:ncbi:9606">Human</span>
###xml 237 243 <span type="species:ncbi:10090">murine</span>
###xml 329 338 <span type="species:ncbi:7955">zebrafish</span>
###xml 350 356 <span type="species:ncbi:8090">medaka</span>
###xml 834 840 <span type="species:ncbi:8090">medaka</span>
All ligands (with the exception of organotins) were screened at concentrations of 0.5, 5, and 50 muM. Of the 27 xenobiotic compounds tested, phthalates and organochlorines were most effective at activating NR1I2 orthologs. Human SXR and murine PXR were readily activated by most phthalates at 5 muM (Table 2), whereas amphibian, zebrafish, fugu, and medaka orthologs were for the most part unaffected, even at the highest concentrations. At 50 muM, all organochlorines except octachlorostyrene induced a > 10-fold increase in luciferase activity relative to vehicle alone in many species (Table 3). Nonprimate mammalian, avian, and amphibian NR1I2 orthologs appeared most susceptible to organochlorine activation and exhibited moderate (4- to 10-fold) to high luciferase activity at 5 muM. With the exception of 2,4-dichlorophenol in medaka, most NR1I2 orthologs were completely insensitive to chlorinated phenols. The organotins, which are cytotoxic at micromolar concentrations, were tested at 1, 10, and 100 nM and failed to induce significant luciferase activity in any species (Table 4). Among the nonorganochlorine pesticides and industrial compounds, only the pyrethroid ester fenvalerate and the alkyl phenol surfactant 4-tert-octylphenol elicited significant luciferase activity at the 5-muM concentration.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 644 676 644 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0116-000880">Kyriazopoulou and Vagenakis 1992</xref>
###xml 946 972 946 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0116-000880">Barditch-Crovo et al. 1999</xref>
###xml 974 990 974 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-ehp0116-000880">Hall et al. 2003</xref>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
Our results show significant variability across species in the capacity of xenobiotics to activate NR1I2 orthologs. Generally speaking, NR1I2 exhibits broad ligand specificity and regulates genes involved in hepatic metabolism of endogenous and xenobiotic compounds. As a result, this transcription factor presents unique challenges with regard to pharmacology and toxicology. For instance, the antibiotic rifampicin, a potent and selective activator of human SXR, can up-regulate hepatic metabolism of steroids to the extent that patients were incorrectly diagnosed with Cushing's syndrome following overnight dexamethasone suppression tests (Kyriazopoulou and Vagenakis 1992). Furthermore, activation of SXR by one therapeutic compound can significantly alter the fate of another. Rifampicin and the herbal supplement St. John's wort have both been shown to increase the clearance of the oral contraceptives ethinylestradiol and norethindrone (Barditch-Crovo et al. 1999; Hall et al. 2003).
###end p 31
###begin p 32
###xml 560 567 560 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 520 525 <span type="species:ncbi:9606">human</span>
###xml 656 661 <span type="species:ncbi:9606">human</span>
###xml 840 846 <span type="species:ncbi:8090">Medaka</span>
###xml 996 1001 <span type="species:ncbi:9606">human</span>
Compounds that activated human SXR also activated SXR in nonhuman primates, but fold induction relative to the vehicle was typically lower in these species. In contrast, the nonprimate mammalian orthologs exhibited higher relative activation for many organochlorines and phthalates when compared to human SXR. Although fold induction of luciferase activity was variable across species for each ligand, all mammalian, avian, and amphibian orthologs appeared to be suitable qualitative models for predicting activation of human SXR with organochlorines. The two Xenopus BXRs had activation profiles similar to each other but were much less predictive of the human SXR response to phthalates compared to mammalian and avian orthologs. In contrast, responses among fish orthologs were so variable that few if any generalizations could be made. Medaka appeared to be insensitive to the vast majority of compounds tested, whereas the fathead minnow appears to be the most relevant model with regard to human SXR activation.
###end p 32
###begin p 33
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 999 1020 999 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0116-000880">Needham and Wang 2002</xref>
###xml 1088 1091 1088 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o,p</italic>
###xml 1143 1146 1143 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p,p</italic>
###xml 1180 1200 1180 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp0116-000880">Damgaard et al. 2006</xref>
###xml 1202 1218 1202 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0116-000880">Shen et al. 2008</xref>
###xml 1519 1535 1519 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0116-000880">Main et al. 2006</xref>
###xml 1807 1823 1806 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000880">Xie et al. 2000a</xref>
###xml 508 529 <span type="species:ncbi:328819|species:ncbi:379362|species:ncbi:219650|species:ncbi:329529|species:ncbi:133823|species:ncbi:261389|species:ncbi:184426|species:ncbi:261384|species:ncbi:302169">environmental samples</span>
###xml 684 689 <span type="species:ncbi:9606">human</span>
###xml 1355 1361 <span type="species:ncbi:9606">infant</span>
###xml 1512 1517 <span type="species:ncbi:9606">women</span>
###xml 1582 1588 <span type="species:ncbi:9606">infant</span>
###xml 1801 1805 <span type="species:ncbi:10090">mice</span>
An important aspect of interpreting the toxicologic relevancy of these data is the comparison of the concentrations that elicit in vitro activation to predicted environmental exposure. One major limitation to analysis is that there is a relative paucity of data concerning the concentrations of chemicals in blood and other biological fluids in response to particular environmental concentrations. Another limitation to meaningful comparisons is that the method of reporting concentrations in biological and environmental samples is quite variable. For instance, the concentrations of many of the same organochlorine pesticides and phthalates used in this study have been measured in human breast milk as an indicator of neonatal exposure. The concentrations of organochlorines and other lipophilic compounds are reported as nanograms per gram lipid, and the major metabolites of phthalates, phthalate monoesters, are reported micrograms per liter. Assuming an average of 3-4% lipid in breast milk (Needham and Wang 2002), molar concentrations of organochlorines such as methoxychlor and o,p'-DDT were typically < 1 nM, whereas endosulfan and p,p'-DDE were in the 10-50 nM range (Damgaard et al. 2006; Shen et al. 2008). Although concentrations in breast milk are an order of magnitude lower than the minimum dose tested (500 nM), the daily intake of the infant should also be considered. Nanomolar to low micromolar concentrations were reported for phthalate monoesters in the breast milk of Danish and Finnish women (Main et al. 2006). Based on the concentrations in breast milk, infant body mass, and average milk consumption, the range of the estimated daily intake of some phthalates exceeded 50 mug/kg/day, the same dose used to up-regulate PXR-responsive genes with known ligands in laboratory mice (Xie et al. 2000a).
###end p 33
###begin p 34
###xml 211 227 211 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0116-000880">Zhai et al. 2007</xref>
###xml 720 736 720 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000880">Xie et al. 2000a</xref>
###xml 528 532 <span type="species:ncbi:10090">Mice</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
Although the toxicologic effects of activating NR1I2 are not completely understood, the metabolic pathways regulated by NR1I2 implicate it as a potential target for disrupting bile acid and steroid homeostasis (Zhai et al. 2007). Further complicating these interactions, xenobiotics that fail to activate this receptor may be more toxic than those that activate it and induce their own metabolism. NR1I2 mediates the metabolism of many drugs, and this metabolism can be induced to a very high level by chronic NR1I2 activation. Mice expressing a constitutively active form of human SXR (Alb-VPSXR) are almost completely resistant to the anesthetic effects of tribromoethanol and zoxaolamine, demonstrating this concept (Xie et al. 2000a).
###end p 34
###begin p 35
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 573 575 573 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 705 734 705 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp0116-000880">Gutendorf and Westendorf 2001</xref>
###xml 986 993 985 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1063 1083 1062 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp0116-000880">Saal and Hughes 2005</xref>
The development of competitive binding and receptor activation assays allows one to estimate the potential for a xenobiotic compound to interact with a single receptor in any species. However, the ability to predict which chemicals will induce a characterized response in vivo at a particular dose, such as uterine proliferation via estrogen receptor (ER) activation, is much more complex. This matter is further complicated when considering exposure to a chemical that activates multiple transcription factors with different affinities. For instance, bisphenol A has an EC50 (half maximal concentration) of approximately 200 nM in ER luciferase reporter assays and the E-Screen cell proliferation assay (Gutendorf and Westendorf 2001). Our data indicate that bisphenol A activates NR1I2-dependent transcription at 50 muM and thus would induce its own metabolism at similar concentrations. Based on these data, one might predict an inverted U-shaped dose-response curve for bisphenol A in vivo, a phenomenon that has been repeatedly reported (for review, see vom Saal and Hughes 2005).
###end p 35
###begin p 36
###xml 211 219 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 280 287 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
A significant difficulty in deriving an accurate risk assessment from laboratory experiments is the uncertainty about whether the underlying mechanisms of response to chemical exposure are universal. The use of in vitro or cell-based assays to guide and refine the development of in vivo models to screen compounds for NR1I2 activation is a useful tool to understand and/or prevent unintended xenobiotic interactions. Our results demonstrate species-specific differences in the ability of NR1I2 orthologs to activate transcription. This suggests that the metabolism, and presumably the physiological effects, of those ligands will also vary across species. Future work screening xenobiotics for toxicologic effects as well as drug-drug interactions should take these data into consideration.
###end p 36
###begin p 37
We thank J. Ycaza for assistance with plasmid preparations.
###end p 37
###begin p 38
This study was supported by grants from the U.S. Environmental Protection Agency (STAR-CR830686) and an unrestricted research gift from Eisai Co, Ltd. to B.B.; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Health Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan, and a grant from the Ministry of Environment, Japan, to T.I. M.R.M. was supported by an institutional training grant from the National Institutes of Health (CA09054-29) and a University of California President's Postdoctoral Fellowship.
###end p 38
###begin p 39
B.B. is a named inventor on U.S. patents related to SXR (6,756,491, 6,809,178, and 6,984,773). The Salk Institute for Biological Studies (La Jolla, CA), which has licensed them to various for-profit entities, controls these patents. The remaining authors declare they have no competing financial interests.
###end p 39
###begin title 40
References
###end title 40
###begin article-title 41
The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive
###end article-title 41
###begin article-title 42
SXR, a novel steroid and xenobiotic-sensing nuclear receptor
###end article-title 42
###begin article-title 43
###xml 38 43 <span type="species:ncbi:9606">human</span>
Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin
###end article-title 43
###begin article-title 44
###xml 25 30 <span type="species:ncbi:9606">human</span>
Persistent pesticides in human breast milk and cryptorchidism
###end article-title 44
###begin article-title 45
The nuclear receptor PXR: a master regulator of "homeland" defense
###end article-title 45
###begin article-title 46
###xml 134 138 <span type="species:ncbi:10116">rats</span>
Effects of a potent catatoxic steroid, 16 -cyanopregnenolone, on microsomal metabolism of steroid hormones, sterols and bile acids in rats
###end article-title 46
###begin article-title 47
PHYLIP - Phylogeny Inference Package (Version 3.2)
###end article-title 47
###begin article-title 48
Benzoate X receptors alpha and beta are pharmacologically distinct and do not function as xenobiotic receptors
###end article-title 48
###begin article-title 49
Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens
###end article-title 49
###begin article-title 50
The interaction between St John's wort and an oral contraceptive
###end article-title 50
###begin article-title 51
The evolution of drug-activated nuclear receptors: one ancestral gene diverged into two xenosensor genes in mammals
###end article-title 51
###begin article-title 52
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution
###end article-title 52
###begin article-title 53
The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism
###end article-title 53
###begin article-title 54
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
###end article-title 54
###begin article-title 55
Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors)
###end article-title 55
###begin article-title 56
CAR and PXR: xenosensors of endocrine disrupters?
###end article-title 56
###begin article-title 57
Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy
###end article-title 57
###begin article-title 58
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
###end article-title 58
###begin article-title 59
Ligation independent cloning irrespective of restriction site compatibility
###end article-title 59
###begin article-title 60
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 103 110 <span type="species:ncbi:9606">infants</span>
Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age
###end article-title 60
###begin article-title 61
Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors
###end article-title 61
###begin article-title 62
Analytic considerations for measuring environmental chemicals in breast milk
###end article-title 62
###begin article-title 63
Hormones and resistance
###end article-title 63
###begin article-title 64
###xml 57 62 <span type="species:ncbi:9606">human</span>
Concentrations of persistent organochlorine compounds in human milk and placenta are higher in Denmark than in Finland
###end article-title 64
###begin article-title 65
###xml 36 41 <span type="species:ncbi:9606">human</span>
Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR)
###end article-title 65
###begin article-title 66
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools
###end article-title 66
###begin article-title 67
An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment
###end article-title 67
###begin article-title 68
###xml 27 32 <span type="species:ncbi:9606">human</span>
2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin
###end article-title 68
###begin article-title 69
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity
###end article-title 69
###begin article-title 70
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Humanized xenobiotic response in mice expressing nuclear receptor SXR
###end article-title 70
###begin article-title 71
Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR
###end article-title 71
###begin article-title 72
Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism
###end article-title 72
###begin article-title 73
Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis
###end article-title 73
###begin p 74
###xml 189 209 189 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-ehp0116-000880">Chrencik et al. 2005</xref>
###xml 211 230 211 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp0116-000880">Watkins et al. 2001</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-ehp0116-000880">2003</xref>
###xml 361 378 361 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000880">Moore et al. 2002</xref>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 393 409 <span type="species:ncbi:9542">Japanese macaque</span>
###xml 425 444 <span type="species:ncbi:9541">crab-eating macaque</span>
Alignment of amino acid sequences of NR1I2 ortholog LBDs. Shaded regions correspond to amino acid residues of the LBD that have been shown to interact with xenobiotic ligands in human SXR (Chrencik et al. 2005; Watkins et al. 2001, 2003). The boxed regions represent the helix 1-3 insert that distinguishes functionally divergent members of the NR1I subfamily (Moore et al. 2002). J. macaque, Japanese macaque; C.E. macaque, crab-eating macaque.
###end p 74
###begin p 75
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 230 246 <span type="species:ncbi:9542">Japanese macaque</span>
###xml 262 281 <span type="species:ncbi:9541">crab-eating macaque</span>
Nonrooted neighbor-joining tree of NR1I2 orthologs and mammalian NR1I3 ligand-binding domains (A), and the percent amino acid identities of NR1I2 otholog ligand-binding domains (B). Abbreviations: FHM, fathead minnow; J. macaque, Japanese macaque; C.E. macaque, crab-eating macaque.
###end p 75
###begin p 76
Compounds tested for their ability to activate NR1I2 orthologs.
###end p 76
###begin p 77
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p,p</italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p,p</italic>
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o,p</italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o,p</italic>
CAS, Chemical Abstracts Service; p,p'-DDE, p,p'-dichlorodiphenyldichloroethylene; o,p'-DDT, o,p' dichlorodiphenyl-trichloroethane.
###end p 77
###begin p 78
Species-specific activation of NR1I2 orthologs by phthalates.
###end p 78
###begin p 79
FHM, fathead minnow. Values represent fold induction of luciferase activity (normalized for beta-galactosidase activity) relative to DMSO treatment.
###end p 79
###begin p 80
###xml 201 202 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 240 258 233 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus laevis BXR</italic>
###xml 264 271 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and BXR</italic>
###xml 275 276 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 66 69 <span type="species:ncbi:9615">dog</span>
###xml 81 87 <span type="species:ncbi:9986">rabbit</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 147 150 <span type="species:ncbi:10116">rat</span>
###xml 182 189 <span type="species:ncbi:9031">chicken</span>
###xml 240 254 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 281 287 <span type="species:ncbi:8090">medaka</span>
###xml 340 349 <span type="species:ncbi:7955">zebrafish</span>
Positive controls were as follows: rifampicin for human, macaque, dog, marmoset, rabbit, and fugu; pregnenolone 16alpha-carbonitrile for mouse and rat; 5beta-3,20 pregnane dione for chicken and quail; p-hydroxy benzoic acid butyl ester for Xenopus laevis BXRalpha and BXRbeta, and medaka; and clotrimazole (cytotoxic at 50 muM) for FHM and zebrafish.
###end p 80
###begin p 81
Species-specific activation of NR1I2 orthologs by organochlorines and phenols.
###end p 81
###begin p 82
FHM, fathead minnow. Values represent fold induction of luciferase activity (normalized for beta-galactosidase activity) relative to DMSO treatment.
###end p 82
###begin p 83
Species-specific activation of NR1I2 orthologs by selected nonorganochlorine pesticides, organotins, and industrial compounds.
###end p 83
###begin p 84
FHM, fathead minnow. Values represent fold induction of luciferase activity (normalized for beta-galactosidase activity) relative to DMSO treatment.
###end p 84

